| Functionally defined therapeutic targets in diffuse intrinsic pontine glioma CS Grasso, Y Tang, N Truffaux, NE Berlow, L Liu, MA Debily, MJ Quist, ... Nature medicine 21 (6), 555-559, 2015 | 678 | 2015 |
| Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations P Buczkowicz, C Hoeman, P Rakopoulos, S Pajovic, L Letourneau, ... Nature genetics 46 (5), 451-456, 2014 | 665 | 2014 |
| Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International … LM Hoffman, SEM Veldhuijzen van Zanten, N Colditz, J Baugh, B Chaney, ... Journal of clinical oncology 36 (19), 1963-1972, 2018 | 390 | 2018 |
| Integrated proteogenomic characterization across major histological types of pediatric brain cancer F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ... Cell 183 (7), 1962-1985. e31, 2020 | 261 | 2020 |
| Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma H Nikbakht, E Panditharatna, LG Mikael, R Li, T Gayden, M Osmond, ... Nature communications 7 (1), 11185, 2016 | 257 | 2016 |
| Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma OJ Becher, D Hambardzumyan, TR Walker, K Helmy, J Nazarian, ... Cancer research 70 (6), 2548-2557, 2010 | 194 | 2010 |
| Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy S Dadgar, Z Wang, H Johnston, A Kesari, K Nagaraju, YW Chen, DA Hill, ... Journal of Cell Biology 207 (1), 139-158, 2014 | 184 | 2014 |
| Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy E Panditharatna, LB Kilburn, MS Aboian, M Kambhampati, ... Clinical Cancer Research 24 (23), 5850-5859, 2018 | 170 | 2018 |
| Histone variant and cell context determine H3K27M reprogramming of the enhancer landscape and oncogenic state S Nagaraja, MA Quezada, SM Gillespie, M Arzt, JJ Lennon, PJ Woo, ... Molecular cell 76 (6), 965-980. e12, 2019 | 152 | 2019 |
| Advances in the proteomic investigation of the cell secretome KJ Brown, CA Formolo, H Seol, RL Marathi, S Duguez, E An, D Pillai, ... Expert review of proteomics 9 (3), 337-345, 2012 | 131 | 2012 |
| Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes AM Saratsis, M Kambhampati, K Snyder, S Yadavilli, JM Devaney, ... Acta neuropathologica 127, 881-895, 2014 | 117 | 2014 |
| A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium S Mueller, P Jain, WS Liang, L Kilburn, C Kline, N Gupta, E Panditharatna, ... International journal of cancer 145 (7), 1889-1901, 2019 | 116 | 2019 |
| ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis CM Hoeman, FJ Cordero, G Hu, K Misuraca, MM Romero, HJ Cardona, ... Nature communications 10 (1), 1023, 2019 | 112 | 2019 |
| Direct analysis of lipids and small metabolites in mouse brain tissue by AP IR-MALDI and reactive LAESI mass spectrometry B Shrestha, P Nemes, J Nazarian, Y Hathout, EP Hoffman, A Vertes Analyst 135 (4), 751-758, 2010 | 109 | 2010 |
| Mass cytometry detects H3. 3K27M-specific vaccine responses in diffuse midline glioma S Mueller, JM Taitt, JE Villanueva-Meyer, ER Bonner, T Nejo, RR Lulla, ... The Journal of clinical investigation 130 (12), 2022 | 106 | 2022 |
| Molecular imaging of biological samples on nanophotonic laser desorption ionization platforms SA Stopka, C Rong, AR Korte, S Yadavilli, J Nazarian, TT Razunguzwa, ... Angewandte Chemie International Edition 55 (14), 4482-4486, 2016 | 106 | 2016 |
| Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid AM Saratsis, S Yadavilli, S Magge, BR Rood, J Perez, DA Hill, E Hwang, ... Neuro-oncology 14 (5), 547-560, 2012 | 92 | 2012 |
| Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma R Kumar, KS Smith, M Deng, C Terhune, GW Robinson, BA Orr, APY Liu, ... Journal of Clinical Oncology 39 (7), 807-821, 2021 | 84 | 2021 |
| PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma NR Fons, RK Sundaram, GA Breuer, S Peng, RL McLean, AN Kalathil, ... Nature communications 10 (1), 3790, 2019 | 83 | 2019 |
| Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways S Venneti, AR Kawakibi, S Ji, SM Waszak, SR Sweha, M Mota, M Pun, ... Cancer discovery 13 (11), 2370-2393, 2023 | 81 | 2023 |
Madhuri KambhampatiChildren's National Medical centercnmc.org의 이메일 확인됨
